thisdrug what a medicine's name tells you

WHO naming stem · suffix · 7 listed names

-ganan

This page was written with AI.

antimicrobials, permeability increasing peptides

WHO's definition, quoted as written in the 2024 stem book

0 of 7 names appear in these lists: 0 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 0 have national brands in at least one EU/EEA country.

Names only. This page is about -ganan as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -ganan. So the letters ganan sit at the end of the name (…ganan).

All 7 names WHO lists under -ganan

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 0 of 7 names appear in these lists: 0 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 0 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. iseganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. lefleuganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. omiganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. peceleganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. pexiganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. upleganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. voxvoganan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Decode another name

Decoded

iseganan

Listed INNCarries the WHO stem -ganan

  • -gananend of the nameWHO lists it hereWHO definition: antimicrobials, permeability increasing peptides

“iseganan” is an INN that WHO lists under -ganan in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -ganan (Part II B) and the 7 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy